In a recent paper, University of Alberta researcher Dr. Matthias Gotte has shown that the drug remdesivir — developed by Gilead Sciences to treat Ebola in 2014 — is highly effective at stopping SARS-CoV-2 from replicating.
Person: Dr. Matthias Gotte
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...